Access to Civil Justice
Woo, Margaret Y K, Cox, Connor, Rosen, Sarah
Published in The American journal of comparative law (21.10.2022)
Published in The American journal of comparative law (21.10.2022)
Get full text
Journal Article
Population pharmacokinetics of intravenous and oral panobinostat in patients with hematologic and solid tumors
Savelieva, Marina, Woo, Margaret M., Schran, Horst, Mu, Song, Nedelman, Jerry, Capdeville, Renaud
Published in European journal of clinical pharmacology (01.06.2015)
Published in European journal of clinical pharmacology (01.06.2015)
Get full text
Journal Article
phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer
Rathkopf, Dana, Wong, Bryan Y, Ross, Robert W, Anand, Aseem, Tanaka, Erika, Woo, Margaret M, Hu, Jing, Dzik-Jurasz, Andy, Yang, Wei, Scher, Howard I
Published in Cancer chemotherapy and pharmacology (01.05.2010)
Published in Cancer chemotherapy and pharmacology (01.05.2010)
Get full text
Journal Article
A randomized dose-escalation study to assess the safety, tolerability, and pharmacokinetics of ruxolitinib (INC424) in healthy Japanese volunteers
Ogama, Yoichiro, Mineyama, Tomoko, Yamamoto, Asuka, Woo, Margaret, Shimada, Naomi, Amagasaki, Taro, Natsume, Kazuto
Published in International journal of hematology (01.03.2013)
Published in International journal of hematology (01.03.2013)
Get full text
Journal Article
A phase I dose-escalation study of intravenous panobinostat in patients with lymphoma and solid tumors
Sharma, Sunil, Beck, Joachim, Mita, Monica, Paul, Sofia, Woo, Margaret M., Squier, Margaret, Gadbaw, Brian, Prince, H. Miles
Published in Investigational new drugs (01.08.2013)
Published in Investigational new drugs (01.08.2013)
Get full text
Journal Article
Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4,4′-methanol-bisbenzonitrile in vitro
Jeong, Seongwook, Woo, Margaret M., Flockhart, David A., Desta, Zeruesenay
Published in Cancer chemotherapy and pharmacology (01.10.2009)
Published in Cancer chemotherapy and pharmacology (01.10.2009)
Get full text
Journal Article
Effect of ketoconazole-mediated CYP3A4 inhibition on clinical pharmacokinetics of panobinostat (LBH589), an orally active histone deacetylase inhibitor
Hamberg, Paul, Woo, Margaret M., Chen, Lin-Chi, Verweij, Jaap, Porro, Maria Grazia, Zhao, Lily, Li, Wenkui, van der Biessen, Diane, Sharma, Sunil, Hengelage, Thomas, de Jonge, Maja
Published in Cancer chemotherapy and pharmacology (01.09.2011)
Published in Cancer chemotherapy and pharmacology (01.09.2011)
Get full text
Journal Article
The effect of food on the bioavailability of panobinostat, an orally active pan-histone deacetylase inhibitor, in patients with advanced cancer
Shapiro, Geoffrey I., Frank, Richard, Dandamudi, Uday B., Hengelage, Thomas, Zhao, Lily, Gazi, Lucien, Porro, Maria Grazia, Woo, Margaret M., Lewis, Lionel D.
Published in Cancer chemotherapy and pharmacology (01.02.2012)
Published in Cancer chemotherapy and pharmacology (01.02.2012)
Get full text
Journal Article
A clinical investigation of inhibitory effect of panobinostat on CYP2D6 substrate in patients with advanced cancer
Feld, Ronald, Woo, Margaret M., Leighl, Natasha, Shepherd, Frances A., Beck, J. Thaddeus, Zhao, Lihui, Gazi, Lucien, Hengelage, Thomas, Porro, Maria Grazia, Nayak, Asha
Published in Cancer chemotherapy and pharmacology (01.10.2013)
Published in Cancer chemotherapy and pharmacology (01.10.2013)
Get full text
Journal Article
Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled 14C material in advanced cancer patients
Clive, Sally, Woo, Margaret M., Nydam, Thomas, Kelly, Lindsay, Squier, Margaret, Kagan, Mark
Published in Cancer chemotherapy and pharmacology (01.10.2012)
Published in Cancer chemotherapy and pharmacology (01.10.2012)
Get full text
Journal Article
Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled super(14)C material in advanced cancer patients
Clive, Sally, Woo, Margaret M, Nydam, Thomas, Kelly, Lindsay, Squier, Margaret, Kagan, Mark
Published in Cancer chemotherapy and pharmacology (01.10.2012)
Published in Cancer chemotherapy and pharmacology (01.10.2012)
Get full text
Journal Article
Characterizing the disposition, metabolism, and excretion of an orally active pan-deacetylase inhibitor, panobinostat, via trace radiolabeled ^sup 14^C material in advanced cancer patients
Clive, Sally, Woo, Margaret M, Nydam, Thomas, Kelly, Lindsay, Squier, Margaret, Kagan, Mark
Published in Cancer chemotherapy and pharmacology (01.10.2012)
Published in Cancer chemotherapy and pharmacology (01.10.2012)
Get full text
Journal Article
Effects of Renal Function on the Pharmacokinetics of Panobinostat in Patients with Advanced Cancer: A Phase I Study
Sharma, Sunil, Voest, Emile, Hagner, Nicole, Witteveen, P.O., Lolkema, Martijn, Agarwal, Neeraj, Valera, Sue-zette, Li, Jason, Mires, Derek, Porro, Maria Grazia, Woo, Margaret M., Hess, Dagmar
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Population Pharmacokinetics of Panobinostat (LBH589) in Patients with Advanced Solid Tumors and Hematologic Malignancies Following Intravenous and Oral Administration
Savelieva, Marina, Woo, Margaret M., Weber, Harald A., Hirawat, Samit, Paul, Sofia, Schindler, Joanne, Fisch, Roland
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
Effects of Hepatic Function on the Pharmacokinetics and Safety of Panobinostat in Patients with Advanced Cancer: A Phase I Study
Hess, Dagmar, Hagner, Nicole, Clive, Sally, Gelderblom, Hans, Rossmann, Eva, Agarwal, Neeraj, Porro, Maria Grazia, Hengelage, Thomas, St-Pierre, Annie, Gazi, Lucien, Li, Jason, Woo, Margaret M., Sharma, Sunil
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
Characteristics of Thrombocytopenia in Patients Treated with Oral Panobinostat (LBH589)
Lin, Rong, Hu, Jing, Paul, Sofia, Schindler, Joanne, Woo, Margaret M., Spence, Stan, Hirawat, Samit, Weber, Harald A.
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
QT Interval Measurements in Patients with Hematologic Malignancies and Solid Tumors Treated with Oral Panobinostat (LBH589)
Weber, Harald A., Tai, Feng, Paul, Sofia, Schindler, Joanne, Woo, Margaret M., Spence, Stan, Marlowe, Jennifer, Lin, Rong
Published in Blood (20.11.2009)
Published in Blood (20.11.2009)
Get full text
Journal Article
Phase IA/II Study of Oral Panobinostat (LBH589), a Novel Pan- Deacetylase Inhibitor (DACi) Demonstrating Efficacy in Patients with Advanced Hematologic Malignancies
Ottmann, Oliver G., Spencer, Andrew, Prince, H. Miles, Bhalla, Kapil N., Fischer, Thomas, Liu, Angela, Parker, Kathryn, Jalaluddin, Muhammad, Laird, Glen, Woo, Margaret, Scott, Jeffrey W., DeAngelo, Daniel J.
Published in Blood (16.11.2008)
Published in Blood (16.11.2008)
Get full text
Journal Article